期刊簡介預計審稿時間：

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.

Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.

《癌癥免疫學研究》發(fā)表優(yōu)秀的原創(chuàng)文章，報道癌癥免疫學的重大進展，涵蓋從宿主-腫瘤相互作用的基礎研究到模型系統(tǒng)中的發(fā)育治療、患者的早期轉(zhuǎn)化研究和后期臨床試驗。該期刊向癌癥研究界傳播免疫學知識，催化跨學科工作，從而加深對宿主-腫瘤關(guān)系的理解，更有效的癌癥治療方法和更好的臨床結(jié)果。

論文經(jīng)過嚴格審查，具體主題包括內(nèi)源性抗腫瘤免疫、促腫瘤炎癥、癌癥抗原、疫苗、抗體、細胞療法、細胞因子、免疫調(diào)節(jié)、免疫抑制、癌癥治療的免疫調(diào)節(jié)作用、新興技術(shù)和臨床研究。該期刊的特色包括“免疫學大師”——由頂尖免疫學家撰寫的入門書——和“癌癥免疫學的十字路口”——強調(diào)免疫學與其他癌癥研究領(lǐng)域和相關(guān)學科的交叉點的觀點。

《Cancer Immunology Research》(癌癥免疫學研究)編輯部通訊方式為615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。如果您需要協(xié)助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發(fā)表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。